David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UDMY
1626
DELISTED
Udemy
UDMY
| $6.05M | 0.01% |
+410,963
| New | +$5.12M |
|
1627
Hilltop Holdings
HTH
$2.21B
| $6.05M | 0.01% |
171,780
+7,637
| +5% | +$231K |
|
1628
Assurant
AIZ
$14.1B
| $6.05M | 0.01% |
35,879
+31,881
| +797% | +$5.07M |
|
1629
Ionis Pharmaceuticals
IONS
$10.6B
| $6.03M | 0.01% |
119,158
-242,887
| -67% | -$11.6M |
|
1630
Everspin Technologies
MRAM
$429M
| $6.03M | 0.01% |
666,701
+26,852
| +4% | +$249K |
|
1631
BlackRock Capital Allocation Term Trust
BCAT
$1.66B
| $6.03M | 0.01% |
403,031
| – | – |
|
1632
CALL
Newell Brands
NWL
$2.53B
| $6.01M | 0.01% |
692,500
+354,800
| +105% | +$2.7M |
|
1633
Enanta Pharmaceuticals
ENTA
$410M
| $6.01M | 0.01% |
638,168
+277,116
| +77% | +$2.58M |
|
1634
Fortuna Silver Mines
FSM
$3.68B
| $5.99M | 0.01% |
1,551,832
+518,995
| +50% | +$1.74M |
|
1635
AXIS Capital
AXS
$7.25B
| $5.99M | 0.01% |
108,122
+46,341
| +75% | +$2.58M |
|
1636
PUT
Peloton Interactive
PTON
$2.36B
| $5.98M | 0.01% |
982,000
-625,000
| -39% | -$3.37M |
|
|
JKS
1637
PUT
JinkoSolar
JKS
$812M
| $5.97M | 0.01% |
161,500
-100
| -0.1% | -$3.23K |
|
|
VGR
1638
DELISTED
Vector Group Ltd.
VGR
| $5.97M | 0.01% |
528,874
+26,643
| +5% | +$289K |
|
1639
Cardlytics
CDLX
$25.2M
| $5.96M | 0.01% |
64,681
-5,613
| -8% | -$571K |
|
1640
CALL
Nutanix
NTNX
$18B
| $5.95M | 0.01% |
124,800
+107,700
| +630% | +$4.36M |
|
1641
CALL
Becton Dickinson
BDX
$51.7B
| $5.95M | 0.01% |
24,400
+9,900
| +68% | +$2.44M |
|
1642
Wyndham Hotels & Resorts
WH
$5.63B
| $5.95M | 0.01% |
+73,966
| New | +$5.56M |
|
1643
Pricesmart
PSMT
$5.47B
| $5.95M | 0.01% |
78,475
+33,304
| +74% | +$2.36M |
|
1644
Celsius Holdings
CELH
$8.94B
| $5.94M | 0.01% |
108,867
-598,776
| -85% | -$32M |
|
1645
Applied Industrial Technologies
AIT
$12.3B
| $5.93M | 0.01% |
34,331
-62,396
| -65% | -$10.1M |
|
1646
FormFactor
FORM
$8.42B
| $5.93M | 0.01% |
142,062
-242,317
| -63% | -$8.86M |
|
|
AIV
1647
Aimco
AIV
$375M
| $5.92M | 0.01% |
755,991
-281,809
| -27% | -$1.9M |
|
|
SPR
1648
CALL
DELISTED
Spirit AeroSystems
SPR
| $5.91M | 0.01% |
186,100
+134,500
| +261% | +$3.3M |
|
1649
CALL
Aon
AON
$75.3B
| $5.91M | 0.01% |
20,300
-3,400
| -14% | -$1.09M |
|
1650
Rhythm Pharmaceuticals
RYTM
$7.8B
| $5.91M | 0.01% |
+128,492
| New | +$4.05M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.